World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
125
Citations
64985
World Ranking
3063
National Ranking
1692

Overview

Douglas B. Evans is affiliated with the Medical College of Wisconsin in the United States. Their research focuses primarily on the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a substantial number of publications totaling 264 and 64 respectively.

The main areas of study for Evans include Oncology, Cancer Research, Surgery, Endocrinology, Diabetes and Metabolism, and Pulmonary and Respiratory Medicine. These subfields reflect the diversity and focus of their scientific investigations.

Evans has contributed to the following primary research topics:

  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Renal Cell Carcinoma Treatment
  • Neuroendocrine Tumor Research Advances
  • Hormonal Regulation and Hypertension
  • Parathyroid Disorders and Treatments
  • Pancreatitis Pathology and Treatment

Their recent publications demonstrate a broad engagement with pancreatic cancer, surgical oncology, and quality of life studies. Notable papers include:

  • "An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study" (2022, Gastroenterology)
  • "Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods" (2020, The American Journal of Surgery)
  • "Long-term Quality of Life After Parathyroidectomy for Primary Hyperparathyroidism" (2022, JAMA Surgery)
  • "Total Neoadjuvant Therapy for Operable Pancreatic Cancer" (2020, Annals of Surgical Oncology)
  • "Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication" (2020, Journal of Gastrointestinal Oncology)

Evans frequently collaborates with other researchers, with some coauthors appearing multiple times. Frequent collaborators include Susan Tsai, Kathleen K. Christians, William A. Hall, Mandana Kamgar, and Mohammed Aldakkak.

Publication venues where Evans has contributed extensively include:

  • Journal of Clinical Oncology
  • Surgery
  • HPB
  • Annals of Surgical Oncology
  • Cancer Research

Best Publications

  • One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

    James C. Yao;Manal Hassan;Alexandria T. Phan;Cecile Dagohoy

  • Revised American thyroid association guidelines for the management of medullary thyroid carcinoma

    Samuel A Wells;Sylvia L Asa;Henning Dralle;Rossella Elisei

  • Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement

    Mary C. Frates;Carol B. Benson;J. William Charboneau;Edmund S. Cibas

  • Medullary thyroid cancer: management guidelines of the American Thyroid Association.

    Richard T. Kloos;Charis Eng;Douglas B. Evans;Gary L. Francis

  • Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression

    Rosa Frances Hwang;Todd Moore;Thiruvengadam Arumugam;Vijaya Ramachandran

  • Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

    Gauri R. Varadhachary;Eric P. Tamm;James L. Abbruzzese;Henry Q. Xiong

  • The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells

    Weixin Wang;James L. Abbruzzese;Douglas B. Evans;Lillie Larry

  • Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

    Matthew H.G. Katz;Peter W.T. Pisters;Douglas B. Evans;Charlotte C. Sun

  • Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

    Douglas B. Evans;Gauri R. Varadhachary;Christopher H. Crane;Charlotte C. Sun

  • Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.

    Douglas B. Evans;Tyvin A. Rich;David R. Byrd;Karen R. Cleary

  • Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas

    Maria A. Kouvaraki;Jaffer A. Ajani;Paulo Hoff;Robert Wolff

  • Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer

    Maria A Kouvaraki;Suzanne E Shapiro;Bruno D Fornage;Beth S Edeiken-Monro

  • Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

    Chandrajit P. Raut;Jennifer F. Tseng;Jennifer F. Tseng;Charlotte C. Sun;Huamin Wang

  • Pancreaticoduodenectomy with vascular resection: margin status and survival duration

    Jennifer F. Tseng;Chandrajit P. Raut;Jeffrey E. Lee;Peter W.T. Pisters

  • Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.

    F. R. Spitz;J. L. Abbruzzese;Jeffrey E Lee;Peter W Pisters

  • Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

    Christiane J. Bruns;Matthew T. Harbison;Darren W. Davis;Charles A. Portera

  • Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

    Matthew Harold Katz;Matthew Harold Katz;Huamin Wang;Jason B Fleming;Charlotte C Sun

  • HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas

    Michael J Gray;Jing Zhang;Jing Zhang;Lee M Ellis;Gregg L Semenza

  • Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

    Gauri R. Varadhachary;Robert A. Wolff;Christopher H. Crane;Charlotte C. Sun

  • NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity

    Shuichi Fujioka;Jiangong Niu;Christian Schmidt;Guido M. Sclabas

Frequent Co-Authors

Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
James L. Abbruzzese
James L. Abbruzzese Duke University
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Peter W.T. Pisters
Peter W.T. Pisters The University of Texas MD Anderson Cancer Center
Christopher H. Crane
Christopher H. Crane Memorial Sloan Kettering Cancer Center
Jason B. Fleming
Jason B. Fleming The University of Texas MD Anderson Cancer Center
Karen R. Cleary
Karen R. Cleary The University of Texas MD Anderson Cancer Center
Huamin Wang
Huamin Wang The University of Texas MD Anderson Cancer Center
Jean Nicolas Vauthey
Jean Nicolas Vauthey The University of Texas MD Anderson Cancer Center
Robert F. Gagel
Robert F. Gagel The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but considering alternate routes beyond a traditional M.D. pathway, there are flexible options available online. Aspiring nurses from non-nursing backgrounds may appreciate the convenience of msn direct entry programs online. These accelerated degrees can quickly put you on a track to advanced practice nursing roles.

Entry requirements and acceptance rates often vary between institutions. If you’re concerned about competitiveness, you may want to consider nursing schools with high acceptance rates, which can offer more accessible routes to launching your healthcare career.

Not all medical careers require clinical work. There is high demand for skilled professionals in healthcare administration as well. Studying at one of the best medical billing and coding schools online can open doors in the growing field of health information management, often with flexible schedules and financial aid options.

Some students prefer programs with fewer standardized exam barriers. If that’s you, explore a nursing school that does not require teas test, allowing you to begin your studies without the stress of additional entrance exams.

Best Scientists Citing Douglas B. Evans

Trending Scientists

Recently Published Articles